welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 468 blog entries.

March 2023 Price Concessions 2nd Update

The Department of Health and Social Care (DHSC) has today (22/03/2023) granted the following list of price concessions for March 2023. Drug Pack size Price concession Bisoprolol 2.5mg tablets 28 £1.18 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £10.29 Clarithromycin 250mg/5ml oral suspension 70 £5.54 Clotrimazole 1% cream 20 £2.29 Co-codamol 30mg/500mg effervescent tablets 32 [...]

The post March 2023 Price Concessions 2nd Update appeared first on PSNC Website.

By |March 22nd, 2023|Lexpos News|Comments Off on March 2023 Price Concessions 2nd Update

Extension to Paracetamol 240mg suppositories (SSP051)

Update 05/05/23 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Paracetamol 240mg suppository (SSP051) was due to expire 5 May 2023 but have been further extended to Friday 12 May 2023. In response to a significant ongoing disruption to the supply of Paracetamol [...]

The post Extension to Paracetamol 240mg suppositories (SSP051) appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on Extension to Paracetamol 240mg suppositories (SSP051)

Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 100mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP049 Estradot® 100mcg patches expires at 23.59pm on Friday 17 March 2023. After this date, any prescriptions for Estradot® 100mcg patches must be [...]

The post Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches

MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (23)A/10 Date issued: 16 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 150mg prolonged-release tablets, PL01883/0340 SNOMED Code: 41468211000001100 Batch [...]

The post MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream. MSN/2023/028 Tier 2 – medium impact Date of issue 16th March 2023 Following intermittent supplies of capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream, these are now out of stock until end of June 2023. [...]

The post Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream appeared first on PSNC Website.

By |March 16th, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream